BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21876668)

  • 1. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation.
    Kang H; Wiedmer A; Yuan Y; Robertson E; Lieberman PM
    PLoS Pathog; 2011 Aug; 7(8):e1002140. PubMed ID: 21876668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency.
    Chen HS; Wikramasinghe P; Showe L; Lieberman PM
    J Virol; 2012 Sep; 86(17):9454-64. PubMed ID: 22740398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions.
    Kang H; Lieberman PM
    J Virol; 2009 Jun; 83(12):6199-210. PubMed ID: 19369356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
    Li D; Mosbruger T; Verma D; Swaminathan S
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.
    Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM
    PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection.
    Toth Z; Smindak RJ; Papp B
    Virology; 2017 Dec; 512():25-33. PubMed ID: 28898712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription.
    Li DJ; Verma D; Mosbruger T; Swaminathan S
    PLoS Pathog; 2014 Jan; 10(1):e1003880. PubMed ID: 24415941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators.
    Stedman W; Kang H; Lin S; Kissil JL; Bartolomei MS; Lieberman PM
    EMBO J; 2008 Feb; 27(4):654-66. PubMed ID: 18219272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
    Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency.
    Hopcraft SE; Pattenden SG; James LI; Frye S; Dittmer DP; Damania B
    PLoS Pathog; 2018 Sep; 14(9):e1007267. PubMed ID: 30212584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KSHV Topologically Associating Domains in Latent and Reactivated Viral Chromatin.
    Campbell M; Chantarasrivong C; Yanagihashi Y; Inagaki T; Davis RR; Nakano K; Kumar A; Tepper CG; Izumiya Y
    J Virol; 2022 Jul; 96(14):e0056522. PubMed ID: 35867573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
    Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.
    Chang PC; Fitzgerald LD; Van Geelen A; Izumiya Y; Ellison TJ; Wang DH; Ann DK; Luciw PA; Kung HJ
    Cancer Res; 2009 Jul; 69(14):5681-9. PubMed ID: 19584288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.